Application of Bioactive Materials for Osteogenic Function in Bone Tissue Engineering
© 2024 Wiley‐VCH GmbH..
Bone tissue defects present a major challenge in orthopedic surgery. Bone tissue engineering using multiple versatile bioactive materials is a potential strategy for bone-defect repair and regeneration. Due to their unique physicochemical and mechanical properties, biofunctional materials can enhance cellular adhesion, proliferation, and osteogenic differentiation, thereby supporting and stimulating the formation of new bone tissue. 3D bioprinting and physical stimuli-responsive strategies have been employed in various studies on bone regeneration for the fabrication of desired multifunctional biomaterials with integrated bone tissue repair and regeneration properties. In this review, biomaterials applied to bone tissue engineering, emerging 3D bioprinting techniques, and physical stimuli-responsive strategies for the rational manufacturing of novel biomaterials with bone therapeutic and regenerative functions are summarized. Furthermore, the impact of biomaterials on the osteogenic differentiation of stem cells and the potential pathways associated with biomaterial-induced osteogenesis are discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Small methods - (2024) vom: 21. März, Seite e2301283 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bai, Yuxin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced techniques |
|---|
| Anmerkungen: |
Date Revised 21.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1002/smtd.202301283 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369994361 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369994361 | ||
| 003 | DE-627 | ||
| 005 | 20240322001600.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/smtd.202301283 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1339.xml |
| 035 | |a (DE-627)NLM369994361 | ||
| 035 | |a (NLM)38509851 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bai, Yuxin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of Bioactive Materials for Osteogenic Function in Bone Tissue Engineering |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2024 Wiley‐VCH GmbH. | ||
| 520 | |a Bone tissue defects present a major challenge in orthopedic surgery. Bone tissue engineering using multiple versatile bioactive materials is a potential strategy for bone-defect repair and regeneration. Due to their unique physicochemical and mechanical properties, biofunctional materials can enhance cellular adhesion, proliferation, and osteogenic differentiation, thereby supporting and stimulating the formation of new bone tissue. 3D bioprinting and physical stimuli-responsive strategies have been employed in various studies on bone regeneration for the fabrication of desired multifunctional biomaterials with integrated bone tissue repair and regeneration properties. In this review, biomaterials applied to bone tissue engineering, emerging 3D bioprinting techniques, and physical stimuli-responsive strategies for the rational manufacturing of novel biomaterials with bone therapeutic and regenerative functions are summarized. Furthermore, the impact of biomaterials on the osteogenic differentiation of stem cells and the potential pathways associated with biomaterial-induced osteogenesis are discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a advanced techniques | |
| 650 | 4 | |a bioactive materials | |
| 650 | 4 | |a bone regeneration | |
| 650 | 4 | |a molecular mechanism | |
| 650 | 4 | |a stem cells | |
| 700 | 1 | |a Wang, Zhaojie |e verfasserin |4 aut | |
| 700 | 1 | |a He, Xiaolie |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Yanjing |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Xu |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Huiyi |e verfasserin |4 aut | |
| 700 | 1 | |a Mei, Guangyu |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Shengguang |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Bei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Rongrong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Small methods |d 2017 |g (2024) vom: 21. März, Seite e2301283 |w (DE-627)NLM287300196 |x 2366-9608 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:21 |g month:03 |g pages:e2301283 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/smtd.202301283 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 21 |c 03 |h e2301283 | ||